Clinical Trials Logo

Clinical Trial Summary

This clinical trial is for patients who have been diagnosed with Kellgren-Lawrence (K&L) Grade 2 or 3 knee osteoarthritis on radiographic examination. Only subjects who voluntarily agree to participate by filling out the written Informed Consent document will undergo screening for subject selection (inclusion/exclusion) criteria, at which time the severity of OA in each knee will be used to determined which knee will be treated (index knee - i.e., the more severely affected knee), and enroll in this study.


Clinical Trial Description

Patients who meet the inclusion/exclusion criteria will be randomly assigned at visit 2 to either of study group 1(low-dose), study group 2 (mid-dose) or active control group at 1:1:1 ratio. Patients will be administered with investigational product. Investigational product will be administered into the to-be-treated (index) knee one time within 7 days after randomization. All patients enrolled will be followed up a total of 6 times (1, 4, 8, 12, 24, and 52 weeks) for up to post-dose 12 months. The patients should visit the study facility according to the visit schedule, and will undergo safety evaluation (vital sign, laboratory test, etc.) and efficacy evaluation [Western Ontario and McMaster Universities osteoarthritis index (WOMAC), 100-mm visual analogue scale (VAS), International Knee Documentation Committee (IKDC) subjective knee evaluation]. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05182034
Study type Interventional
Source Medipost Co Ltd.
Contact Eunyoung Lee
Phone +82234656748
Email [email protected]
Status Not yet recruiting
Phase Phase 2
Start date January 21, 2022
Completion date August 30, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT04651673 - Prescribed Knee Brace Treatments for Osteoarthritis of the Knee (Knee OA)
Active, not recruiting NCT04043819 - Evaluation of Safety and Exploratory Efficacy of an Autologous Adipose-derived Cell Therapy Product for Treatment of Single Knee Osteoarthritis Phase 1
Recruiting NCT05160246 - The Instant Effect of Kinesiology Taping in Patients With Knee OA N/A
Active, not recruiting NCT05014542 - Needling Techniques for Knee Osteoarthritis N/A
Active, not recruiting NCT03472300 - Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
Recruiting NCT04017533 - Stability of Uncemented Medially Stabilized TKA N/A
Completed NCT04779164 - The Relation Between Abdominal Obesity, Type 2 Diabetes Mellitus and Knee Osteoarthritis N/A
Recruiting NCT04006314 - Platelet Rich Plasma and Neural Prolotherapy Injections in Treating Knee Osteoarthritis N/A
Enrolling by invitation NCT04145401 - Post Market Clinical Follow-Up Study- EVOLUTION® Revision CCK
Active, not recruiting NCT03781843 - Effects of Genicular Nerve Block in Knee Osteoarthritis N/A
Recruiting NCT04749628 - Cannabidiol for Bilateral Total Knee Arthroplasty Phase 4
Completed NCT04589858 - Effect of Manual Therapies With Supervised Exercise Protocol on Pain and Functional Disability in Patients With Knee OA N/A
Recruiting NCT04592562 - Genicular Artery Embolization to Reduce Pain Associated With Unilateral Mild to Moderate Osteoarthritis N/A
Not yet recruiting NCT03825965 - Cannabinoids vs. Placebo on Persistent Post-surgical Pain Following TKA: A Pilot RCT Phase 3
Not yet recruiting NCT04885972 - Study to Evaluate Intra-articular Resiniferatoxin to Treat Moderate to Severe Pain From Knee Osteoarthritis Phase 2
Not yet recruiting NCT04968132 - Opioid Reduction in Orthopaedic Surgery (OREOS) - Knees N/A
Not yet recruiting NCT04331990 - The Distraction of Knee Joint to Alleviate osteoArthritic Pain (DiKAP) Trial N/A
Not yet recruiting NCT05062499 - The Effects of Home Use of Transcutaneous Electrical Nerve Stimulation on People With Knee OA and or Chronic Knee Pain N/A
Not yet recruiting NCT04257682 - Regional Anesthesia in Total Hip and Knee Arthroplasty Phase 4
Not yet recruiting NCT04040764 - Uncemented Tritanium TKR vs Cemented Triathlon TKR N/A